Updated just now · Live
Stock analysis, price data, and AI-powered insights for Evaxion A/S (EVAX).
Evaxion A/S operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for EVAX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). EVAX Stock Intelligence Report. [stoxpulse.com/stocks/evax]
Disclaimer: The information on this page about Evaxion A/S (EVAX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Evaxion A/S.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Evaxion's Announces Its Data Demonstrating AI-Immu...
3d ago
Evaxion’s AI-Immunology™ platform demonstrates 86%...
3d ago
StoxPulse AI results for EVAX: Pulse Score 51.5/100. Primary sentiment trends from 5 news sources and 0 SEC filings indicate a bullish outlook.
Market Cap
$37.1M
P/E Ratio
—
EPS
—
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Evaxion's Announces Its Data Demonstrating AI-Immunology Traces, Selects Therapeutically Relevant Vaccine Targets; 88% Vaccine Targets Trigger Tumor-Specific Immune Response
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Evaxion Showcases AI-Immunology Platform's Potential To Develop Glioblastoma Vaccines Using Novel Tumor Targets At AACR
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Evaxion concludes Annual General Meeting